CytoSorbents (NASDAQ:CTSO) reported quarterly losses of $(0.07) per share which missed the analyst consensus estimate of $(0.05) by 40 percent. This is a 50 percent increase over losses of $(0.14) per share from the same period last year. The company reported quarterly sales of $9.234 million which missed the analyst consensus estimate of $9.587 million by 3.68 percent. This is a 0.92 percent increase over sales of $9.150 million the same period last year.